Zentalis Pharmaceuticals, Inc. (ZNTL) valuation
Share price $2.34 · As of last filing 2026-03-31
Special situation detected — historical normalisation may not reflect go-forward economics.
EPV and Reverse-DCF outputs below are anchored on history that
no longer represents the entity going forward
(net cash > 50% of market cap)
.
Inspect the balance sheet, recent 8-K filings, and the cards
above before relying on these models.
- net cash > 50% of market cap. Net cash $173.1M (cash $211.8M − debt $38.7M) = 103.9% of market cap $166.6M